- CV Sciences, Inc. entered into a note purchase agreement on **October 6, 2025**, and issued a **$600,000** secured promissory note to an institutional investor, with the transaction closing on **October 7, 2025**.  **[1510964_0001193125-25-237188_cvsi-20251007.htm:1]** 
- The note included an original issuance discount of **$150,000**, and the company paid an additional **$150,000** to the investor for modifying a previous agreement, resulting in **net proceeds of $300,000**.  **[1510964_0001193125-25-237188_cvsi-20251007.htm:1]** 
- The note has a maturity date of **April 6, 2027**, and requires monthly repayments of **$46,153.85** starting on **April 6, 2026**.  **[1510964_0001193125-25-237188_cvsi-20251007.htm:1]** 
- This financing is **secured by all of the Company's assets and its subsidiaries' assets**, including intellectual property.  **[1510964_0001193125-25-237188_cvsi-ex10_4.htm:0]** **[1510964_0001193125-25-237188_cvsi-20251007.htm:1]**

CV Sciences, Inc. Issues Senior Secured Note

- CV Sciences, Inc. entered into an agreement on **September 12, 2025**, to amend the terms of a **$1,600,000** Secured Promissory Note with an institutional investor.  **[1510964_0001193125-25-207436_cvsi-ex10_1.htm:0]** **[1510964_0001193125-25-207436_cvsi-20250912.htm:1]** 
- The maturity date of the Note has been extended from August 12, 2026, to **February 12, 2027**.  **[1510964_0001193125-25-207436_cvsi-ex10_1.htm:0]** **[1510964_0001193125-25-207436_cvsi-20250912.htm:1]** 
- The monthly redemption schedule for the Note was revised to **$106,666.67** for the first 3 months, followed by **$0** for the next 6 months, and then **$106,666.67** for the subsequent 12 months.  **[1510964_0001193125-25-207436_cvsi-ex10_1.htm:0]** **[1510964_0001193125-25-207436_cvsi-20250912.htm:1]** 
- As consideration for these amendments, the company will provide the investor with **$150,000** in cash.  **[1510964_0001193125-25-207436_cvsi-ex10_1.htm:0]** **[1510964_0001193125-25-207436_cvsi-20250912.htm:1]**

CV Sciences (CVSI)